Page last updated: 2024-12-06

7-ethylbenz(a)anthracene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

7-Ethylbenz(a)anthracene (7-EBA) is a polycyclic aromatic hydrocarbon (PAH) that has been identified as a potent carcinogen. It is a derivative of benz(a)anthracene, with an ethyl group attached at the 7-position. 7-EBA is typically found in combustion products, such as coal tar, diesel exhaust, and cigarette smoke. It has been shown to be mutagenic and carcinogenic in various animal models, and its presence in environmental samples has raised concerns about its potential health risks. 7-EBA's synthesis can be achieved through various methods, including the Friedel-Crafts alkylation of benz(a)anthracene with ethyl chloride. The compound's effects, particularly its carcinogenic properties, have driven extensive research into its mechanisms of action and potential mitigation strategies. 7-EBA is a valuable tool in studying the carcinogenic effects of PAHs and the development of new cancer prevention strategies.'

Cross-References

ID SourceID
PubMed CID19430
CHEMBL ID4296690
MeSH IDM0153834

Synonyms (18)

Synonym
AKOS005444324
7-ethylbenz(a)anthracene
benz(a)anthracene, 7-ethyl-
brn 1875998
ccris 1534
10-ethyl-1,2-benzanthracene
7-ethyltetraphene
STK368371
7-ethylbenzo[a]anthracene
3697-30-1
benz[a]anthracene, 7-ethyl-
7-ethylbenzo[a]anthracene #
HBFJJKFTOQAJHO-UHFFFAOYSA-N
7-ethylbenz[a]anthracene
DTXSID10190466
7-ethylbenzo[b]phenanthrene
10-athyl-l,2-benzanthracen
CHEMBL4296690
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.46 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]